Oscar Tahuahua/X
Mar 19, 2025, 15:48
Oscar Tahuahua: Systematic Review and Meta-analysis in HER2+ Breast Cancer Patients
Oscar Tahuahua, Medical Oncology Fellow at National Cancer Institute(Mexico), shared an article by Shunsuke Nakatani, et al. on X:
“Systematic Review and Meta-analysis in HER2+ Breast Cancer Patients.
HER2 loss post NACT (21.4%) linked to higher recurrence (HR 1.85, p=0.0005) & worse OS (HR 2.37, p=0.0065).
Mechanisms: tumor heterogeneity, acquired resistance & clonal selection. Should HER2 reassessment guide tx?”
Impact of loss of HER2 positivity following neoadjuvant therapy in HER2 positive breast cancer patients on long-term prognosis: A systematic review and meta-analysis.
Authors: Shunsuke Nakatani, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 18:57
Apr 15, 2025, 18:26
Apr 15, 2025, 17:49
Apr 15, 2025, 17:41